These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18822656)

  • 1. Risk factors of cardiovascular disease among the oral contraceptive users in Kermanshah City of Iran.
    Malek-Khosravi S
    J Pak Med Assoc; 2008 Aug; 58(8):473-4. PubMed ID: 18822656
    [No Abstract]   [Full Text] [Related]  

  • 2. Alesse: leading the shift to 20 microg.
    Archer DF
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):37-8. PubMed ID: 10561673
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88.
    Graff-Iversen S; Tverdal A; Stensvold I
    Contraception; 1996 Jun; 53(6):337-44. PubMed ID: 8773420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of long-acting contraceptives.
    Vekemans M
    Lancet; 1995 Oct; 346(8983):1165. PubMed ID: 7475634
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
    Goldzieher JW
    J Reprod Med; 1983 Jan; 28(1 Suppl):53-6. PubMed ID: 6403700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel.
    Nurs Times; 2005 Jan 11-17; 101(2):31. PubMed ID: 15688918
    [No Abstract]   [Full Text] [Related]  

  • 9. [Back up contraception].
    Dacheva T
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():28-31. PubMed ID: 19504704
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation.
    Lancet; 1998 Aug; 352(9126):428-33. PubMed ID: 9708750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral venous thrombosis associated with repeated use of emergency contraception.
    Horga A; Santamarina E; Quilez A; de Francisco J; Garcia-Martinez R; Alvarez-Sabin J
    Eur J Neurol; 2007 Apr; 14(4):e5. PubMed ID: 17388977
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined hormonal contraception unsuitable together with lamotrigine].
    Lakartidningen; 2010 Oct 27-Nov 2; 107(43):2654. PubMed ID: 21137535
    [No Abstract]   [Full Text] [Related]  

  • 13. [Emergency contraception ].
    Amaliev G
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():19-24. PubMed ID: 19504703
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteers.
    Butler K; Teng R
    Curr Med Res Opin; 2011 Aug; 27(8):1585-93. PubMed ID: 21692601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Escapelle - a method of choice for emergency contraception ].
    Tanchev L
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():24-7. PubMed ID: 19496450
    [No Abstract]   [Full Text] [Related]  

  • 16. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with a low-dose contraceptive agent. European studies.
    Haspels AA
    J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick S; Kaye JA; Li L; Jick H
    Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer non-oral hormonal contraception.
    Bateson D; McNamee K; Briggs P
    BMJ; 2013 Feb; 346():f341. PubMed ID: 23412438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.